NEURO LIGHT

GOAL

Evaluation of the efficacy of photobiomodulation (PBM) therapy in the management of chemotherapy-induced neuropathy.

STUDY DESIGN

Randomized pilot trial with patients diagnosed with chemotherapy-induced neuropathy.  This study started in February 2022. 

Laser group 1 (n=15)	Laser group 2 (n=15)
PBM (2x/week, for 3 weeks)	PBM (2x/week, for 3 weeks)
Lasertherapy with a dosage of 6 J/cm²	Lasertherapy with a dosage of 8 J/cm²

STUDY RESULTS

Study is still active and no preliminary results are available.

PUBLICATIONS

 

PARTNERS